BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3329405)

  • 1. Biochemical and immunologic diagnosis of cancer. Renal and transitional carcinomas.
    Cordon-Cardo C
    Tumour Biol; 1987; 8(2-3):94-102. PubMed ID: 3329405
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous renal cell carcinoma of the kidney and transitional cell carcinoma of the bladder.
    Hasan WA; Al-Bareeq R; Durazi M; Al-Muttawa S
    Can J Urol; 2002 Jun; 9(3):1565-7. PubMed ID: 12121583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical case of the simultaneous development of a tumor of the renal parenchyma and of a transitional-cell carcinoma of the ureter and bladder].
    Kotsev R; Stratev S; Karaivanov M
    Khirurgiia (Sofiia); 1997; 50(1):78-9. PubMed ID: 9379632
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and immunologic diagnosis of cancer. Urinary bladder cancer.
    Paulie S
    Tumour Biol; 1987; 8(2-3):103-4. PubMed ID: 3448760
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell and tumor markers' immunohistochemistry in transitional cell carcinoma of the bladder.
    Lopez-Beltran A; Croghan GA; Croghan I; Gaeta JF
    Urol Int; 1993; 50(2):61-4. PubMed ID: 8460449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Seltz LM; Herrell SD
    Curr Opin Urol; 2016 May; 26(3):259-63. PubMed ID: 26914060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
    Torenbeek R; Blomjous CE; Quak JJ; Ybema S; Meijer CJ
    J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of synchronous triple primary carcinomas of the kidney, bladder and prostate].
    Satoh H; Momma T; Saito S; Hirose S
    Hinyokika Kiyo; 2003 May; 49(5):261-4. PubMed ID: 12822453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
    Pizza G; De Vinci C
    J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of tumors of the kidney and bladder with differing histology].
    Donovski L; Ormanov I
    Khirurgiia (Sofiia); 1990; 43(1):85-7. PubMed ID: 2395292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypernephroma associated with primary bladder tumor. Report of a case].
    Hermida Pérez JA; Del Corral Suarez T; Cerdeiras Martínez G; Ochoa Undargarain O
    Arch Esp Urol; 2000 Mar; 53(2):174-6. PubMed ID: 10802926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers in the diagnosis and prognosis of bladder cancer.
    Lange PH; Limas C
    Urology; 1984 Apr; 23(4 Suppl):46-54. PubMed ID: 6369720
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunodiagnosis of renal cell carcinoma.
    Ebert T; Bander NH
    Immunol Ser; 1990; 53():469-83. PubMed ID: 2100572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of asymptomatic renal cell carcinomas utilizing modern radiographic techniques.
    Sigalow DA; Waldbaum RS; Lowe FC
    N Y State J Med; 1991 May; 91(5):200-2. PubMed ID: 1857572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of bladder tumor invasion with the mixed cell agglutination test.
    Johnson JD; Lamm DL
    J Urol; 1980 Jan; 123(1):25-8. PubMed ID: 7351715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies against renal tumors: the potential application in discrimination of ambiguous adenocarcinoma or transitional cell carcinoma of kidney.
    Yu DS; Chang SY; Ma CP
    J Urol; 1998 Jan; 159(1):48-51. PubMed ID: 9400434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine cytology, tumour markers and bladder cancer.
    Halachmi S; Linn JF; Amiel GE; Moskovitz B; Nativ O
    Br J Urol; 1998 Nov; 82(5):647-54. PubMed ID: 9839578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.